Citigroup Global Markets Inc.
388 Greenwich Street
New York, New York 10013
SVB Leerink LLC
1301 Avenue of the Americas, 12th Floor
New York, New York 10019
Evercore Group L.L.C.
55 East 52nd Street
New York, New York 1005
Citigroup Global Markets Limited
Citigroup Centre
Canada Square
Canary Wharf
London E14 5LB
United Kingdom
October 11, 2019
United States Securities and Exchange Commission
Division of Corporation Finance
Mail Stop 4720
100 F Street, N.E.
Washington, D.C. 20549
Attn:
Donald Field
Dietrich King
Keira Nakada
Lisa Vanjoske
Re: | Innate Pharma S.A. |
Registration Statement on FormF-1
Registration FileNo. 333-233865
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended (the “Act”), we, as representatives of the several underwriters, hereby join in the request of Innate Pharma S.A. (the “Company”) for acceleration of the effective date of the above-named Registration Statement so that it becomes effective at 4:30 PM, Eastern Time, on October 16, 2019 or as soon thereafter as practicable, or at such other time as the Company or its outside counsel, Cooley LLP, request by telephone that such Registration Statement be declared effective.
Pursuant to Rule 460 under the Act, we, as representatives of the several underwriters, wish to advise you that we have effected the following distribution of the Company’s Preliminary Prospectus dated October 4, 2019:
(i) | Dates of distribution: October 7, 2019 through the date hereof |
(ii) | Number of prospective underwriters to which the preliminary prospectus was furnished: 4 |
(iii) | Number of prospectuses furnished to investors: approximately 1100 |
(iv) | Number of prospectuses distributed to others, including the Company, the Company’s counsel, independent accountants, and underwriters’ counsel: approximately 400 |
We, the undersigned, as representatives of the several underwriters, have complied and will comply, and we have been informed by the participating underwriters that they have complied and will comply, with the requirements of Rule15c2-8 under the Securities Exchange Act of 1934, as amended.
Very truly yours, | ||||
CITIGROUP GLOBAL MARKETS INC. | ||||
Acting on behalf of itself and the several underwriters | ||||
By: | CITIGROUP GLOBAL MARKETS INC. | |||
By: | /s/ Kristian Humer | |||
Name: | Kristian Humer | |||
Title: | Managing Director |
Very truly yours, | ||||
SVB LEERINK INC. | ||||
Acting on behalf of itself and the several underwriters | ||||
By: | SVB LEERINK INC. | |||
By: | /s/ Gabriel P. Cavazos | |||
Name: | Gabriel P. Cavazos | |||
Title: | Managing Director |
Very truly yours, | ||||
EVERCORE GROUP L.L.C. | ||||
Acting on behalf of itself and the several underwriters | ||||
By: | EVERCORE GROUP L.L.C. | |||
By: | /s/ Simon Elliott | |||
Name: | Simon Elliott | |||
Title: | Senior Managing Director |
Very truly yours, | ||||
CITIGROUP GLOBAL MARKETS LIMITED | ||||
Acting on behalf of itself and the several underwriters | ||||
By: | CITIGROUP GLOBAL MARKETS LIMITED | |||
By: | /s/ Kristian Humer | |||
Name: | Kristian Humer | |||
Title: | Managing Director |